Latest market price
12.76
+0.15+1.19%
Earnings
Up 1.2% — Earnings due 2026-11-04 — pre-report positioning.
Medium confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | 0.04 | Insider Own | 4.85% | Shs Outstand | 152.38M | Perf Week | 4.33% |
| Market Cap | 1.94B | Forward P/E | — | EPS next Y | 0.04 | Insider Trans | 0.00% | Shs Float | 121.61M | Perf Month | 13.73% |
| Enterprise Value | 3.82B | PEG | — | EPS next Q | -0.04 | Short Float | 8.95% | Perf Quarter | 2.65% | ||
| Income | 27.00M | P/S | 1.41 | EPS this Y | — | Short Ratio | 6.22 | Perf Half Y | 52.81% | ||
| Sales | 1.38B | P/B | 0.90 | EPS next Y | — | ROA | 0.52% | Short Interest | 10.89M | Perf YTD | 71.28% |
| Book/sh | 14.21 | P/C | 2.07 | EPS next 5Y | — | ROE | 1.26% | 52W High | 12.95 -1.47% | Perf Year | 84.13% |
| Cash/sh | 6.16 | P/FCF | 7.28 | EPS past 3/5Y | -47.10% — | ROIC | 11.84% | 52W Low | 6.68 91.02% | Perf 3Y | 32.92% |
| Dividend Est. | 0.60 (4.70%) | EV/EBITDA | 11.47 | Sales past 3/5Y | 4.18% 23.76% | Gross Margin | -4.99% | Volatility | 2.13% 2.66% | Perf 5Y | -12.90% |
| Dividend TTM | 0.60 (4.70%) | EV/Sales | 2.76 | EPS Y/Y TTM | -80.92% | Oper. Margin | 9.52% | ATR (14) | 0.31 | Perf 10Y | -38.62% |
| Dividend Ex-Date | Sep 30, 2026 | Quick Ratio | 1.94 | Sales Y/Y TTM | 1.10% | Profit Margin | 1.98% | RSI (14) | 74.54 | Recom | 2.94 |
| Dividend Gr. 3/5Y | 71.00% 71.88% | Current Ratio | 1.94 | EPS Q/Q | 6.67% | SMA20 | 7.26% | Beta | 1.14 | Target Price | 11.75 |
| Payout | 425.28% | Debt/Eq | 1.30 | Sales Q/Q | 5.51% | SMA50 | 11.95% | Rel Volume | 1.01 | Prev Close | 12.61 |
| Employees | 75 | LT Debt/Eq | 1.07 | Earnings | Nov 04 | SMA200 | 28.82% | Avg Volume | 1.83M | Price | 12.76 |
| IPO Date | May 11, 2011 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 7.02% 3.37% | Net Debt/EBITDA | 5.63 | Volume | 1,841,392 | Change | 1.19% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-13-26 | Reiterated | Barclays | Underweight | $11 → $12 |
| Sep-28-26 | Downgrade | Raymond James | Outperform → Market Perform | |
| Aug-27-26 | Reiterated | Barclays | Underweight | $9.50 → $11 |
| Jul-23-26 | Reiterated | Wells Fargo | Underweight | $9.00 → $11 |
| Jul-21-26 | Reiterated | Barclays | Underweight | $9.00 → $9.50 |
| Jun-18-26 | Reiterated | UBS | $10 → $13 | |
| Jun-01-26 | Reiterated | Barclays | Underweight | $6.00 → $9.00 |
| May-28-26 | Downgrade | Raymond James | Strong Buy → Outperform | $11 |
| Jan-06-26 | Initiated | Barclays | Underweight | $15 → $6.00 |
| Oct-03-25 | Reiterated | Robert W. Baird | $12 → $7.50 |
Latest News· Times ET
Oct-31-26
Oct-30-26
06:20AM
Oct-25-26
Oct-25-2608:00AM
Oct-19-26
Oct-13-26
Oct-13-2608:29AM
Oct-09-26
Oct-06-26
Oct-06-2610:15AM
Oct-02-26
Sep-28-26
Sep-23-26
Sep-22-26
Sep-21-26
Sep-21-2605:09AM
Sep-15-26
Sep-14-26
Sep-14-2608:00AM
Company
RLJ Lodging Trust functions as a self-managed, publicly listed real estate investment trust (REIT). Its core holdings consist primarily of upscale, branded hotels known for their strong profitability and efficient operations, specifically those categorized as focused-service or compact full-service. The Trust's extensive portfolio includes 103 properties, housing approximately 22,570 guest rooms, strategically situated across 23 U.S. states and the District of Columbia. Furthermore, the company holds a partial interest in one unconsolidated hotel, which provides 171 rooms.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,382 | 1,350 | 1,369 | 1,326 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,451 | 1,362 | 985 | 935 | — | — | — | — | — | |
| Gross Profit | -69 | -12 | 384 | 391 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 50 | 48 | 55 | 59 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -250 | -186 | 179 | 179 | — | — | — | — | — | |
| Operating Income | 132 | 126 | 150 | 153 | — | — | — | — | — | |
| Interest Expense | 111 | 112 | 105 | 93 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 8 | 16 | 24 | 18 | — | — | — | — | — | |
| Net Income Before Taxes | 30 | 30 | 70 | 78 | — | — | — | — | — | |
| Income Taxes | 0 | 1 | 2 | 1 | — | — | — | — | — | |
| Consolidated Net Income | 27 | 29 | 68 | 76 | — | — | — | — | — | |
| Net Income From Continuing Operations | 28 | 29 | 68 | 77 | — | — | — | — | — | |
| Net Income | 27 | 29 | 68 | 76 | — | — | — | — | — | |
| EPS (Recurring) | 0.04 | 0.01 | 0.27 | 0.32 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.04 | 0.01 | 0.27 | 0.32 | — | — | — | — | — | |
| EPS (Diluted) | 0.04 | 0.01 | 0.27 | 0.32 | — | — | — | — | — | |
| EBITDA | 333 | 318 | 359 | 355 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 319.00 | 503.38 | 37.81 | 36.63 | — | — | — | — | — | |
| Price To Sales Ratio | 1.38 | 0.83 | 1.14 | 1.38 | — | — | — | — | — | |
| Gross Margin | -4.99 | -0.89 | 28.05 | 29.49 | — | — | — | — | — | |
| Operating Margin | 9.55 | 9.33 | 10.96 | 11.54 | — | — | — | — | — | |
| Net Margin | 1.95 | 2.15 | 4.97 | 5.73 | — | — | — | — | — | |
| Shares Outstanding | 150 | 150 | 153 | 156 | — | — | — | — | — | |
| Market Capitalization | 1,914 | 1,118 | 1,562 | 1,828 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Zeigler Robin McBride | Director | Nov 21 '25 | Sale | 7.51 | 13,413 | 100,732 | 37,159 | Nov 25 |
| Gibson Patricia L | Director | Mar 28 '25 | Buy | 8.03 | 10,000 | 80,298 | 124,217 | Mar 31 |
| Gibson Patricia L | Director | Mar 07 '25 | Buy | 9.38 | 10,000 | 93,783 | 114,217 | Mar 10 |
| Collins Arthur Reginald | Director | Dec 22 '23 | Sale | 11.92 | 25,000 | 298,000 | 30,758 | Dec 26 |
| DAVIS NATHANIEL A | Director | Nov 10 '23 | Sale | 9.87 | 39,594 | 390,793 | 43,423 | Nov 14 |
| Gibson Patricia L | Director | Sep 29 '22 | Buy | 56.67 | 8,098 | 458,913 | 4,049 | May 08 |
| Gibson Patricia L | Director | Sep 23 '22 | Buy | 10.47 | 5,000 | 52,350 | 79,635 | Sep 27 |
| DAVIS NATHANIEL A | Director | Mar 18 '22 | Sale | 14.40 | 40,000 | 576,000 | 62,674 | Mar 22 |
| Gibson Patricia L | Director | Mar 10 '20 | Buy | 10.07 | 2,500 | 25,175 | 48,508 | Mar 11 |
| Gibson Patricia L | Director | Mar 09 '20 | Buy | 10.51 | 2,500 | 26,275 | 46,008 | Mar 11 |
| Gibson Patricia L | Director | Mar 05 '20 | Buy | 12.62 | 5,000 | 63,100 | 43,508 | Mar 09 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.